BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16382177)

  • 1. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis.
    Carter JE; Yu J; Choi NW; Hough J; Henderson D; He D; Langridge WH
    Mol Biotechnol; 2006 Jan; 32(1):1-15. PubMed ID: 16382177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses.
    Dénes B; Yu J; Fodor N; Takátsy Z; Fodor I; Langridge WH
    Mol Biotechnol; 2006 Nov; 34(3):317-27. PubMed ID: 17284779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens.
    Denes B; Krausova V; Fodor N; Timiryasova T; Henderson D; Hough J; Yu J; Fodor I; Langridge WH
    J Immunother; 2005; 28(5):438-48. PubMed ID: 16113600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HIV-1 tat-autoantigen fusion protein suppresses insulitis in NOD mice.
    Kim TG; Yu J; Hough J; Henderson D; Langridge WH
    Mol Biotechnol; 2005 Jul; 30(3):221-9. PubMed ID: 15988047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantigens plus interleukin-10 suppress diabetes autoimmunity.
    Dénes B; Fodor I; Langridge WH
    Diabetes Technol Ther; 2010 Aug; 12(8):649-61. PubMed ID: 20615107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.
    Odumosu O; Payne K; Baez I; Jutzy J; Wall N; Langridge W
    Immunobiology; 2011 Apr; 216(4):447-56. PubMed ID: 20956025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli.
    Gong Z; Long X; Pan L; Le Y; Liu Q; Wang S; Guo J; Xiao B; Zhou M; Mei D
    Protein Expr Purif; 2009 Aug; 66(2):191-7. PubMed ID: 19364533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.
    Williams NA; Hirst TR; Nashar TO
    Immunol Today; 1999 Feb; 20(2):95-101. PubMed ID: 10098329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional pentameric formation via coexpression of the Escherichia coli heat-labile enterotoxin B subunit and its fusion protein subunit with a neutralizing epitope of ApxIIA exotoxin improves the mucosal immunogenicity and protection against challenge by Actinobacillus pleuropneumoniae.
    Kim JM; Park SM; Kim JA; Park JA; Yi MH; Kim NS; Bae JL; Park SG; Jang YS; Yang MS; Kim DH
    Clin Vaccine Immunol; 2011 Dec; 18(12):2168-77. PubMed ID: 22030372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin.
    Ran XQ; Wang HZ; Liu JJ; Li S; Wang JF
    Vet Microbiol; 2008 Feb; 127(1-2):209-15. PubMed ID: 17920213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65).
    Pleau JM; Fernandez-Saravia F; Esling A; Homo-Delarche F; Dardenne M
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):90-5. PubMed ID: 7606872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of non-obese diabetic mice from autoimmune diabetes by Escherichia coli heat-labile enterotoxin B subunit.
    Ola TO; Williams NA
    Immunology; 2006 Feb; 117(2):262-70. PubMed ID: 16423062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus.
    Kim TG; Kim BG; Kim MY; Choi JK; Jung ES; Yang MS
    Mol Biotechnol; 2010 Jan; 44(1):14-21. PubMed ID: 19657748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory expression and purification of recombinant Escherichia coli heat-labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus.
    Cao S; Zhang Y; Liu F; Wang Q; Zhang Q; Liu Q; Li C; Liang M; Li D
    Mol Biotechnol; 2009 Feb; 41(2):91-8. PubMed ID: 19089660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of immune response in young and aged mice vaccinated with corn-derived antigen against Escherichia coli heat-labile enterotoxin.
    Karaman S; Cunnick J; Wang K
    Mol Biotechnol; 2006 Jan; 32(1):31-42. PubMed ID: 16382180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides.
    Wang H; Yang J; Jin L; Feng J; Lu Y; Sun Y; Li T; Cao R; Wu J; Fan H; Liu J
    Immunol Invest; 2009; 38(8):690-703. PubMed ID: 19860582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras.
    Jobling MG; Holmes RK
    Infect Immun; 2002 Mar; 70(3):1260-71. PubMed ID: 11854209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
    Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
    J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.